Fluorine 18-tagged fluorodeoxyglucose positron emission tomographic scanning to predict lymph node metastasis, invasiveness, or both, in clinical T1 NO MO lung adenocarcinoma

被引:33
|
作者
Nomori, H
Watanabe, K
Ohtsuka, T
Naruke, T
Suemasu, K
Kobayashi, T
Uno, K
机构
[1] Saiseikai Cent Hosp, Dept Thorac Surg, Minato Ku, Tokyo 1080073, Japan
[2] Natl Canc Ctr, Endoscopy Div, Tokyo, Japan
[3] Nishidai Clin, Tokyo, Japan
来源
关键词
D O I
10.1016/j.jtcvs.2004.03.020
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: We sought to predict lymph node metastasis and tumor invasiveness in clinical T1 N0 M0 lung adenocarcinomas, and we measured fluorodeoxyglucose uptake on positron emission tomography. Methods: Fluorodeoxyglucose positron emission tomography was performed on 44 patients with adenocarcinomas of 1 to 3 cm in size clinically staged as T1 N0 M0 before major lung resection with lymph node dissection. Fluorodeoxyglucose uptake was evaluated by using the contrast ratio between the tumor and contralateral healthy lung tissue. Lymphatic and vascular invasion within tumors, pleural involvement, and grade of histologic differentiation were examined. Results: The pathologic tumor stage was T1 N0 M0 in 36 patients, and a more advanced stage was found in 8 patients. Although all 22 adenocarcinomas with a contrast ratio of less than 0.5 in fluorodeoxyglucose uptake were pathologic T1 N0 M0 tumors, 8 (36%) of 22 with a contrast ratio of 0.5 or greater were of a more advanced stage than T1 N0 M0, with the difference being significant (P = .002). Adenocarcinomas with a contrast ratio of less than 0.5 showed less lymphatic and vascular invasion and less pleural involvement than those with a contrast ratio of 0.5 or greater (P = .006, P = .004, and P = .02, respectively). The grade of histologic differentiation was well differentiated in 19 of 22 adenocarcinomas with a contrast ratio of less than 0.5 (86%), which was a greater frequency than the 4 (18%) of 22 adenocarcinomas with a contrast ratio of 0.5 or greater (P < .001). Conclusion: Clinical T1 N0 M0 lung adenocarcinomas with a contrast ratio of less than 0.5 usually did not have lymph node metastasis, had less tumor involvement of vessels or pleura, and were more frequently well differentiated than those with a contrast ratio of 0.5 or greater. Limited lung resection could be indicated, lymph node dissection or mediastinoscopy could be reduced, or both in this type of adenocarcinoma.
引用
收藏
页码:396 / 401
页数:6
相关论文
共 44 条
  • [41] 3D multi-scale, multi-task, and multi-label deep learning for prediction of lymph node metastasis in T1 lung adenocarcinoma patients' CT images
    Zhao, Xingyu
    Wang, Xiang
    Xia, Wei
    Zhang, Rui
    Jian, Junming
    Zhang, Jiayi
    Zhu, Yechen
    Tang, Yuguo
    Li, Zhen
    Liu, Shiyuan
    Gao, Xin
    COMPUTERIZED MEDICAL IMAGING AND GRAPHICS, 2021, 93
  • [42] Prediction of lymph node metastasis using 5-point visual scale criteria of [18F]-fluoro-2-deoxy-D-glucose on positron emission tomography / computed tomography for early stage lung adenocarcinoma.
    Kagimoto, Atsushi
    Tsutani, Yasuhiro
    Handa, Yoshinori
    Mimae, Takahiro
    Miyata, Yoshihiro
    Okada, Morihito
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [43] Lymph node metastasis in Chinese patients with clinical T1 non-small cell lung cancer: A multicenter real-world observational study (vol 10, pg 533, 2019)
    Chen, B.
    Wang, X.
    Yu, X.
    Xia, W.
    Zhao, H.
    Li, X.
    Liu, L.
    Liu, Y.
    Hu, J.
    Fu, X.
    Li, Y.
    Xu, Y.
    Liu, D.
    Yang, H.
    Jiang, F.
    THORACIC CANCER, 2019, 10 (09) : 1852 - 1852
  • [44] METABOLIC ACTIVITY ON [18F]-FLUORODEOXYGLUCOSE-POSITRON EMISSION TOMOGRAPHY/ COMPUTED TOMOGRAPHY AND GLUCOSE TRANSPORTER-1 EXPRESSION MAY PREDICT CLINICAL OUTCOMES IN PATIENTS WITH LIMITED DISEASE OF SMALL CELL LUNG CANCER RECEIVING CONCURRENT CHEMORADIATION
    Lee, Jieun
    Kim, Jung Oh
    Jung, Chan Kwon
    Kim, Yeon Shil
    Yoo, Ie Ryung
    Choi, Woo Hee
    Jeon, Eun Kyung
    Hong, Sook Hee
    Chun, Sang Hoon
    Kim, Seung Joon
    Kim, Young Kyoon
    Kang, Jin Hyoung
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S1011 - S1011